This website is no longer being updated. Please visit GBCHealth’s new website at:



Eli Lilly CEO Lechleiter Calls for Urgent Action on Tuberculosis

In honor of World TB Day on March 24, John Lechleiter, President and CEO of Eli Lilly, wrote an article in Forbes calling for urgent global action to fight tuberculosis (TB.)  “As we mark World TB Day…there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat – one that must be urgently addressed,” Lechleiter wrote.

Eli Lilly is taking action on this global health crisis by collaborating with Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Sanofi and four academic institutions to identify faster-acting TB drug candidates. “Above all, we need more coordinated, high-profile global advocacy for TB control,” Lechleiter concluded.

Read article